News

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...
Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.
Once dismissed as “junk,” a group of RNA molecules has been found to help regrow damaged nerves in mice in new research. The ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...
Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...